# Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

> **NCT05952882** · PHASE3 · UNKNOWN · sponsor: **Mỹ Đức Hospital** · enrollment: 188 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Obesity
- Infertility, Female

## Interventions

- **DRUG:** Liraglutide + Metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05952882
- **Lead sponsor:** Mỹ Đức Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05952882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05952882, "Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05952882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*